MWPCG
ARMP icon

Measured Wealth Private Client Group’s Armata Pharmaceuticals ARMP Stock Holding History

Measured Wealth Private Client Group’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48K Hold
1,000
– – ﹤0.01% 607
2026
Q1 		$10.2K Hold
1,000
– – ﹤0.01% 565
2025
Q4 		$6.28K Hold
1,000
– – ﹤0.01% 590
2025
Q3 		$2.98K Buy
+1,000
New +$2.59K ﹤0.01% 627

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Measured Wealth Private Client Group's ARMP Position: Q2 2026 in Review

Measured Wealth Private Client Group held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 1,000 shares worth $6.48K. The position accounts for ﹤0.01% of the portfolio, ranked #607.

Measured Wealth Private Client Group first reported a position in ARMP in Q3 2025 and has held it in 4 quarters since. The position peaked at $10.2K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Measured Wealth Private Client Group held 1,000 shares of Armata Pharmaceuticals worth $6.48K as of Q2 2026.
  • Measured Wealth Private Client Group left its Armata Pharmaceuticals share count unchanged in Q2 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #607 holding.
  • Measured Wealth Private Client Group first reported a position in Armata Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Measured Wealth Private Client Group's Armata Pharmaceuticals position peaked at $10.2K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.